饮食质量与非肌层浸润性膀胱癌预后:Be-Well研究
该前瞻性队列纳入1143例新诊断原发性非肌层浸润性膀胱癌(NMIBC)成人,评估诊断前12个月饮食质量与约2年复发和进展风险的关系。四种饮食质量指数中,2020健康饮食指数(HEI)最高四分位与较低复发风险相关(HR=0.72;95%CI 0.52-0.99),在未接受丝裂霉素C膀胱内化疗者中更明显(HR=0.60;95%CI 0.41-0.90),未观察到与进展的关联。
要点
- HEI最高四分位与NMIBC复发风险降低相关(HR=0.72;95%CI 0.52-0.99)。
- 未接受丝裂霉素C者中该关联更明显(HR=0.60;95%CI 0.41-0.90)。
- 四种饮食质量指数均未显示与疾病进展相关。
核心结论
- 四种饮食质量指数中,仅HEI最高四分位与较低NMIBC复发风险相关,尤其在未接受丝裂霉素C治疗的患者中。
- 饮食质量可能是NMIBC生存者中重要的可改变风险因素。
研究设计与样本
- 在大型整合医疗系统内开展的前瞻性队列研究。
- 2015至2019年纳入1143例新诊断原发性NMIBC成人,诊断前12个月饮食摄入用食物频率问卷评估。
- 计算四种饮食质量指数(美国癌症协会指南、替代健康饮食指数、2020健康饮食指数、健康植物性饮食指数)并四分位分组。
- 诊断后约2年通过病历回顾确定复发和进展,采用Kaplan-Meier曲线和多变量校正风险比(HR)及95%置信区间(CI),并按治疗分层分析。
主要发现
- 1143例参与者中,2年内325例(28.4%)复发,52例(4.5%)进展。
- HEI最高四分位与最低四分位相比,复发风险降低(HR=0.72;95%CI 0.52-0.99)。
- 在未接受膀胱内丝裂霉素C化疗的患者中,HEI最高四分位与最低四分位相比复发风险降低更明显(HR=0.60;95%CI 0.41-0.90)。
- 四种饮食质量指数均未观察到与进展的关联。
临床怎么用
- 对NMIBC患者,尤其未接受丝裂霉素C膀胱内化疗者,可关注并评估饮食质量。
- HEI可作为饮食质量评估工具之一,最高四分位饮食质量与较低复发风险相关。
局限性
- 饮食摄入基于食物频率问卷,存在回忆偏倚可能。
- 复发和进展通过诊断后约2年病历回顾确定,随访时间较短。
- 研究为观察性设计,不能确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether diet quality around the time of diagnosis is associated with risks of recurrence and progression among individuals with non-muscle invasive bladder cancer (NMIBC). METHODS: We conducted a prospective cohort study within a large integrated healthcare system. A total of 1,143 adults with newly diagnosed primary NMIBC were enrolled between 2015 and 2019. Dietary intake 12 months prior was assessed using food frequency questionnaires. Four diet quality indices were calculated-American Cancer Society guidelines, alternative Healthy Eating Index, 2020 Healthy Eating Index (HEI), Healthy Plant-Based Dietary Index-and then categorized into quartiles (Q). Recurrence and progression were determined through chart review approximately 2 years after diagnosis. Kaplan-Meier curves visualized recurrence-free survival, and multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (CI) were estimated, with analyses stratified by treatment. RESULTS: Among the 1,143 participants, 325 (28.4%) experienced recurrence and 52 (4.5%) had progression over 2 years. Higher diet quality was associated with lower recurrence risk for the HEI (Q4 vs Q1: HR=0.72; 95% CI, 0.52-0.99). In stratified analyses, lower recurrence risk was more pronounced among patients who did not receive intravesical chemotherapy mitomycin C (Q4 vs Q1 HR=0.60; 95% CI, 0.41-0.90). No associations were observed for progression. CONCLUSIONS: Of the four diet quality indices, the highest HEI quartile was associated with lower NMIBC recurrence risk, particularly among patients not treated with mitomycin C. Diet quality may be an important modifiable risk factor in NMIBC survivorship.
引用
- Ergas IJ, Zimbalist A, Haque R, et al. Diet quality and prognosis in patients with non-muscle invasive bladder cancer: the Be-Well Study. Urology. 2026. PMID: 42880421. doi:10.1016/j.urology.2026.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。